Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

The current (or longstanding?) problems here is both financial and leadership-based (noting that leadership is DOING THE RIGHT THINGS):

1) More dilution is coming because they don't have the money to run phase 3 (from what I can tell). The cycle of life in penny land, not surprising. where will the money come from you ask?

2) the guys at the helm are paying themselves like kings despite the fact the company has no revenues and this, like many other penny lands stocks, should not be publicly traded because these guys are taking the money of the investor and putting it in their pocket, offering the investor PROMISES of big gains.

3)the guys at the helm are playing a PR game which involves pumping and dumping the SP. I mean this stock has been a ROLLER COASTER ride. It's nauseating. My patience is thin, but bear with me... my point is attested to by the recent flop news release which did not spin things in the correct light. That followed up by Williams going on air saying "don't worry, we still have IPF" thereby basically announcing COVID trial isn't what he expected

I mean come on...